GPC3 CAR T Cells with IL-15 and IL-21

· Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GPC3 CAR T Cells with IL-15 and IL-21, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: GPC3 CAR T Cells With IL-15 and IL-21 for Recurrent ATRT and CNS Rhabdoid Tumors (RADIANT) [Phase 1]